45963-565
Generic: Ezetimibe and Simvastatin
Labeler: Actavis Pharma, Inc.Drug Facts
Product Profile
Brand Name
Generic Name
Ezetimibe and Simvastatin
Labeler
Actavis Pharma, Inc.
Dosage Form
TABLET
Active Ingredients
EZETIMIBE 10 mg/1, SIMVASTATIN 10 mg/1
Identifiers & Regulatory
Product NDC
45963-565
Product ID
45963-565_1cdf591a-b169-4131-b000-b975fe2c9820
Product Type
DRUG FOR FURTHER PROCESSING
Marketing Category
DRUG FOR FURTHER PROCESSING
Marketing Start
2017-04-26
Marketing End
2026-02-28
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
45963565
Hyphenated Format
45963-565
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ezetimibe and simvastatin (source: label)
Generic Name
Ezetimibe and Simvastatin (source: ndc)
Application Number
ANDA202968 (source: label)
Routes
source: label
Resolved Composition
Strengths
- 10 mg/1
Packaging
- 5000 TABLET in 1 BOX (45963-565-00)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"spl_id": "1cdf591a-b169-4131-b000-b975fe2c9820", "openfda": {}, "finished": false, "packaging": [{"description": "5000 TABLET in 1 BOX (45963-565-00)", "package_ndc": "45963-565-00", "marketing_end_date": "28-FEB-26", "marketing_start_date": "26-APR-17"}], "product_id": "45963-565_1cdf591a-b169-4131-b000-b975fe2c9820", "dosage_form": "TABLET", "product_ndc": "45963-565", "generic_name": "Ezetimibe and Simvastatin", "labeler_name": "Actavis Pharma, Inc.", "product_type": "DRUG FOR FURTHER PROCESSING", "brand_name_base": null, "active_ingredients": [{"name": "EZETIMIBE", "strength": "10 mg/1"}, {"name": "SIMVASTATIN", "strength": "10 mg/1"}], "marketing_category": "DRUG FOR FURTHER PROCESSING", "marketing_end_date": "20260228", "marketing_start_date": "20170426"}